Works matching IS 03618609 AND DT 2020 AND VI 95 AND IP 12

Results: 34
    1

    CORRIGENDUM.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1628, doi. 10.1002/ajh.26030
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin‐American cohort of 212 patients.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. E323, doi. 10.1002/ajh.25987
    By:
    • Lazzarino, Carolina;
    • Arbelbide, Jorge;
    • Schuster, Sergio;
    • Crisp, Renée;
    • González, Jacqueline;
    • Tavares, Renato;
    • Perusini, Maria Agustina;
    • Di Stefano, Marco;
    • Pintos, Noemí;
    • Espinosa, Daniel;
    • Pimentel, Mayra;
    • Rosenhain, Mariana;
    • Serrano, Juan Carlos;
    • Enrico, Alicia;
    • Iastrebner, Marcelo;
    • Belli, Carolina B.
    Publication type:
    Article
    10
    11

    Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3).

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. E326, doi. 10.1002/ajh.25991
    By:
    • Sasaki, Koji;
    • Montalban‐Bravo, Guillermo;
    • Kanagal‐Shamanna, Rashmi;
    • Jabbour, Elias;
    • Ravandi, Farhad;
    • Kadia, Tapan;
    • Daver, Naval;
    • Pemmaraju, Naveen;
    • Konopleva, Marina;
    • Borthakur, Gautam;
    • Takahashi, Koichi;
    • Patel, Keyur;
    • Soltysiak, Kelly A.;
    • Chien, Kelly S.;
    • Sakurai, Kenichi;
    • Pierce, Sherry;
    • Kantarjian, Hagop M.;
    • Garcia‐Manero, Guillermo
    Publication type:
    Article
    12
    13

    High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1542, doi. 10.1002/ajh.25989
    By:
    • Yu, Yafei;
    • Wang, Miaomiao;
    • Hou, Yu;
    • Qin, Ping;
    • Zeng, Qingshu;
    • Yu, Wenzheng;
    • Guo, Xinhong;
    • Wang, Jingxia;
    • Wang, Xiaomin;
    • Liu, Guoqiang;
    • Chu, Xiaoxia;
    • Yang, Lan;
    • Feng, Ying;
    • Zhou, Fang;
    • Sun, Zhaogang;
    • Zhang, Mei;
    • Wang, Xin;
    • Wang, Zhencheng;
    • Ran, Xuehong;
    • Zhao, Hongguo
    Publication type:
    Article
    14
    15

    Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1553, doi. 10.1002/ajh.25992
    By:
    • Fajgenbaum, David C.;
    • Wu, David;
    • Goodman, Aaron;
    • Wong, Raymond;
    • Chadburn, Amy;
    • Nasta, Sunita;
    • Srkalovic, Gordan;
    • Mukherjee, Sudipto;
    • Leitch, Heather;
    • Jayanthan, Raj;
    • Ferrero, Simone;
    • Sato, Yasuharu;
    • Schey, Steve;
    • Dispenzieri, Angela;
    • Oksenhendler, Eric;
    • Zinzani, Pier Luigi;
    • Lechowicz, Mary Jo;
    • Hoffmann, Christian;
    • Pemmaraju, Naveen;
    • Bagg, Adam
    Publication type:
    Article
    16

    Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial (EDI‐PIO) in chronic myeloid leukemia with deep molecular response.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. E321, doi. 10.1002/ajh.25986
    By:
    • Pagnano, Katia B.B.;
    • Lopes, Ana Beatriz P.;
    • Miranda, Eliana C.;
    • Delamain, Márcia T.;
    • Duarte, Gislaine O.;
    • Rodrigues, Bruna R.V.;
    • Povoa, Valquiria M.O.;
    • Furlin, Graziele C.P.;
    • Vianna, Jessica C.;
    • Silva, Matheus A.S.;
    • De Souza, Carmino A;
    • De Paula, Erich V
    Publication type:
    Article
    17
    18
    19

    Thrombosis in COVID‐19.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1578, doi. 10.1002/ajh.25982
    By:
    • Hanff, Thomas C.;
    • Mohareb, Amir M.;
    • Giri, Jay;
    • Cohen, Jordana B.;
    • Chirinos, Julio A.
    Publication type:
    Article
    20
    21
    22
    23
    24

    Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1473, doi. 10.1002/ajh.25961
    By:
    • Varettoni, Marzia;
    • Ferrari, Angela;
    • Frustaci, Anna M.;
    • Ferretti, Virginia V.;
    • Rizzi, Rita;
    • Motta, Marina;
    • Piazza, Francesco;
    • Merli, Michele;
    • Benevolo, Giulia;
    • Visco, Carlo;
    • Laurenti, Luca;
    • Ferrero, Simone;
    • Gentile, Massimo;
    • Del Fabro, Vittorio;
    • Abbadessa, Antonio;
    • Klersy, Catherine;
    • Musto, Pellegrino;
    • Fabbri, Nicole;
    • Deodato, Marina;
    • Dogliotti, Irene
    Publication type:
    Article
    25
    26

    Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1466, doi. 10.1002/ajh.25957
    By:
    • Candoni, Anna;
    • Lazzarotto, Davide;
    • Ferrara, Felicetto;
    • Curti, Antonio;
    • Lussana, Federico;
    • Papayannidis, Cristina;
    • Del Principe, Maria Ilaria;
    • Bonifacio, Massimiliano;
    • Mosna, Federico;
    • Delia, Mario;
    • Minetto, Paola;
    • Gottardi, Michele;
    • Fracchiolla, Nicola;
    • Mancini, Valentina;
    • Forghieri, Fabio;
    • Zappasodi, Patrizia;
    • Cerrano, Marco;
    • Vitale, Antonella;
    • Audisio, Ernesta;
    • Trappolini, Silvia
    Publication type:
    Article
    27
    28
    29

    Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1503, doi. 10.1002/ajh.25973
    By:
    • Mir, Farheen;
    • Mattiello, Federico;
    • Grigg, Andrew;
    • Herold, Michael;
    • Hiddemann, Wolfgang;
    • Marcus, Robert;
    • Seymour, John F.;
    • Bolen, Christopher R.;
    • Knapp, Andrea;
    • Nielsen, Tina;
    • Casulo, Carla
    Publication type:
    Article
    30

    A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1457, doi. 10.1002/ajh.25958
    By:
    • Saygin, Caner;
    • Larkin, Karilyn;
    • Blachly, James S.;
    • Orwick, Shelley;
    • Ngankeu, Apollinaire;
    • Gregory, Charles T.;
    • Phelps, Mitch A.;
    • Mani, Shylaja;
    • Walker, Alison;
    • Garzon, Ramiro;
    • Vasu, Sumithira;
    • Walsh, Katherine J.;
    • Bhatnagar, Bhavana;
    • Klisovic, Rebecca B.;
    • Grever, Michael R.;
    • Marcucci, Guido;
    • Byrd, John C.;
    • Blum, William;
    • Mims, Alice S.
    Publication type:
    Article
    31
    32

    "ITP" is not always immune thrombocytopenia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 12, p. 1614, doi. 10.1002/ajh.25872
    By:
    • Holyome, Alexandra;
    • Cooper, Nichola;
    • Qureshi, Amrana;
    • Bain, Barbara J.
    Publication type:
    Article
    33
    34